Neither p53 (Fig. 3) nor CypD (Fig. 2) can essentially direct cytotoxicity of 3-BrPA in T24, therefore uncoupling p53/CypD-complex necrotic activity (which mainly controls mitochondrial PTPC opening) from drug-induced regulated necrosis of bladder cancer cells. Here, TP53 is linked to urinary bladder carcinoma.